Related Experiment Video
Updated: Feb 24, 2026
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
4.4K
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
Matthew E Randolph1, Megan M Cleary1,2, Zia Bajwa1
1Children's Cancer Therapy Development Institute, Beaverton, Oregon, United States of America.
Plos One
|August 18, 2017
Summary
Targeting EphB4 receptor tyrosine kinase showed limited effectiveness for treating pediatric rhabdomyosarcoma (RMS). Therapies inhibiting EphB4 signaling did not significantly improve tumor progression in preclinical models, indicating it
Area of Science:
- Oncology
- Molecular Biology
- Pediatric Cancer Research
Background:
- Rhabdomyosarcoma (RMS) is the most common pediatric soft tissue sarcoma, frequently presenting with metastases.
- Current therapies offer limited improvement in long-term survival for metastatic RMS.
- EphB4 receptor tyrosine kinase is a potential therapeutic target in RMS.
Purpose of the Study:
- To evaluate the efficacy of targeting EphB4 in alveolar (aRMS) and embryonal (eRMS) rhabdomyosarcoma.
- To assess direct inhibition via antibody VasG3 and indirect blockade of EphB4/EphrinB2 signaling.
Main Methods:
- Utilized orthotopic xenograft and allograft models for aRMS and eRMS.
- Administered inhibitory antibody VasG3 targeting EphB4.
- Tested soluble EphB4-murine serum albumin fusion protein to block forward signaling.
Main Results:
- EphB4 expression in eRMS correlated with longer patient survival.
- VasG3 treatment did not alter tumor progression in aRMS or eRMS models.
- Soluble EphB4 partially slowed progression in aRMS but not eRMS models.
Conclusions:
- Direct or indirect inhibition of EphB4 signaling is not a viable monotherapy for rhabdomyosarcoma.
- Further research is needed to identify effective therapeutic strategies for pediatric RMS.
More Related Videos
Related Concept Videos
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.7K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.7K
02:38Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
506
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
506
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:27Transducer Mechanism: Enzyme-Linked Receptors
4.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.5K